Prostate Cancer Cells and Bone Marrow Endothelium
Author Information
Author(s): Scott L J, Clarke N W, George N J R, Shanks J H, Testa N G, Lang S H
Primary Institution: CRC Experimental Haematology Group, Paterson Institute for Cancer Research, Christie Hospital NHS Trust
Hypothesis
Prostate cancer cells have a higher binding affinity to bone marrow endothelium compared to other types of endothelium.
Conclusion
Malignant prostate epithelial cells bind to bone marrow endothelium and show increased invasive ability, while non-malignant cells do not.
Supporting Evidence
- The PC3 cell line showed significantly increased binding to bone marrow endothelium compared to other endothelium types.
- Malignant prostate epithelial cells demonstrated a 1000-fold increase in invasive ability in response to bone marrow endothelium.
Takeaway
This study found that prostate cancer cells stick better to bone marrow than other cells, and only the cancerous ones can invade it.
Methodology
The study used in vitro assays to compare the binding and invasion of prostate cancer cells to different types of endothelium.
Participant Demographics
Primary prostatic epithelial cells from both malignant (n = 11) and non-malignant tissue (n = 11).
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website